Skip to main content

Table 2 Type of newly prescribed treatment and reason for GP consultation among colorectal cancer and matched cancer-free controls in the 6 months before index date, stratified by tumour site

From: A steep increase in healthcare seeking behaviour in the last months before colorectal cancer diagnosis

  Proximal Distal Rectum
Cases Cancer-free controls Cases Cancer-free controls Cases Cancer-free controls
N = 1,910
n (%)
N = 7,640
n (%)
N = 2,022
n (%)
N = 8,088
n (%)
N = 1,926
n (%)
N = 7,704
n (%)
Common newly prescribed medication
A06AD
  Osmotically acting laxatives 729 (38) 175 (2) 928 (46) 194 (2) 914 (48) 173 (2)
A06AB
  Contact laxatives 260 (14) 32 (< 0.5) 426 (21) 47 (1) 444 (23) 36 (1)
A02BC
  Proton pump inhibitors 288 (15) 373 (5) 182 (9) 377 (5) 143 (7) 337 (4)
B03AA
  Iron bivalent, oral preparations 273 (14) 32 (< 0.5) 71 (4) 42 (1) 31 (2) 25 (< 0.5)
A06AG
  Enemas 40 (2) 22 (< 0.5) 117 (6) 35 (< 0.5) 50 (3) 23 (< 0.5)
M01AB
  Acetic acid derivatives and related substances 116 (6) 303 (4) 106 (5) 300 (4) 76 (4) 323 (4)
Common reason for GP consultation
D75
  Malignant neoplasm colon/rectum 664 (35) 1 (< 0.5) 780 (39) 2 (< 0.5) 860 (45) 0 (0)
D16
  Rectal bleeding 10 (1) 13 (< 0.5) 94 (5) 11 (< 0.5) 78 (4) 12 (< 0.5)
B80
  Iron deficiency anaemia 99 (5) 9 (< 0.5) 27 (1) 10 (< 0.5) 15 (1) 2 (< 0.5)
B82
  Anaemia other/unspecified 64 (3) 11 (< 0.5) 12 (1) 10 (< 0.5) 9 (1) 12 (< 0.5)
D06
  Abdominal pain localized other 44 (2) 21 (< 0.5) 41 (2) 37 (1) 9 (1) 14 (< 0.5)